Histochemistry and Cell Biology

, Volume 121, Issue 6, pp 493–499

Mepe is expressed during skeletal development and regeneration

  • Chuanyong Lu
  • Steve Huang
  • Theodore Miclau
  • Jill A. Helms
  • Céline Colnot
Original Paper

Abstract

Matrix extracellular phosphoglycoprotein (Mepe) is a bone metabolism regulator that is expressed by osteocytes in normal adult bone. Here, we used an immunohistochemical approach to study whether Mepe has a role in murine long bone development and regeneration. Our data showed that Mepe protein was produced by osteoblasts and osteocytes during skeletogenesis, as early as 2 days postnatal. During the healing of non-stabilized tibial fractures, which occurs through endochondral ossification, Mepe expression was first detected in fibroblast-like cells within the callus by 6 days postfracture. By 10 and 14 days postfracture (the hard callus phase of repair), Mepe was expressed within late hypertrophic chondrocytes and osteocytes in the regenerating tissues. Mepe became externalized in osteocyte lacunae during this period. By 28 days postfracture (the remodeling phase of repair), Mepe continued to be robustly expressed in osteocytes of the regenerating bone. We compared the Mepe expression profile with that of alkaline phosphatase, a marker of bone mineralization. We found that both Mepe and alkaline phosphatase increased during the hard callus phase of repair. In the remodeling phase of repair, Mepe expression levels remained high while alkaline phosphatase activity decreased. We also examined Mepe expression during cortical bone defect healing, which occurs through intramembranous ossification. Mepe immunostaining was found within fibroblast-like cells, osteoblasts, and osteocytes in the regenerating bone, through 5 to 21 days postsurgery. Thus, Mepe appears to play a role in both long bone regeneration and the latter stages of skeletogenesis.

Keywords

Cartilage Osteomalacia Hypophosphatemia Osteogenesis Immunostaining 

References

  1. Albrecht UEG, Helms JA, Lin H (1997) Visualization of gene expression patterns by in situ hybridization. In: Daston GP (ed) Molecular and cellular methods in developmental toxicology. CRC Press, Boca Raton, pp 23–48Google Scholar
  2. Argiro L, Desbarats M, Glorieux FH, Ecarot B (2001) Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone. Genomics 74:342–351CrossRefPubMedGoogle Scholar
  3. Boden SD, Kaplan FS (1990) Calcium homeostasis. Orthop Clin North Am 21:31–42PubMedGoogle Scholar
  4. Bonnarens F, Einhorn TA (1984) Production of a standard closed fracture in laboratory animal bone. J Orthop Res 2:97–101PubMedGoogle Scholar
  5. Colnot C, Thompson Z, Miclau T, Werb Z, Helms JA (2003) Altered fracture repair in the absence of MMP9. Development 130:4123–4133CrossRefPubMedGoogle Scholar
  6. Doppelt SH (1984) Vitamin D, rickets, and osteomalacia. Orthop Clin North Am 15:671–686PubMedGoogle Scholar
  7. Gowen LC, Petersen DN, Mansolf AL, Qi H, Stock JL, Tkalcevic GT, Simmons HA, Crawford DT, Chidsey-Frink KL, Ke HZ, et al (2003) Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 278:1998–2007CrossRefPubMedGoogle Scholar
  8. Guo R, Rowe PS, Liu S, Simpson LG, Xiao ZS, Darryl Quarles LD (2002) Inhibition of Mepe cleavage by Phex. Biochem Biophys Res Commun 297:38–45CrossRefPubMedGoogle Scholar
  9. Igarashi M, Kamiya N, Ito K, Takagi M (2002) In situ localization and in vitro expression of osteoblast/osteocyte factor 45 mRNA during bone cell differentiation. Histochem J 34:255–263CrossRefPubMedGoogle Scholar
  10. Le AX, Miclau T, Hu D, Helms JA (2001) Molecular aspects of healing in stabilized and non-stabilized fractures. J Orthop Res 19:78–84CrossRefPubMedGoogle Scholar
  11. Lieberman JR, Daluiski A, Einhorn TA (2002) The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 84-A:1032–1044Google Scholar
  12. MacDougall M, Simmons D, Gu TT, Dong J (2002) Mepe/OF45, a new dentin/bone matrix protein and candidate gene for dentin diseases mapping to chromosome 4q21. Connect Tissue Res 43:320–330PubMedGoogle Scholar
  13. Nelson AE, Robinson BG, Mason RS (1997) Oncogenic osteomalacia: is there a new phosphate regulating hormone? Clin Endocrinol (Oxf) 47:635–642Google Scholar
  14. Petersen DN, Tkalcevic GT, Mansolf AL, Rivera-Gonzalez R, Brown TA (2000) Identification of osteoblast/osteocyte factor 45 (OF45), a bone-specific cDNA encoding an RGD-containing protein that is highly expressed in osteoblasts and osteocytes. J Biol Chem 275:36172–36180CrossRefPubMedGoogle Scholar
  15. Quarles LD (2003) FGF23, PHEX, and Mepe regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 285:E1–E9PubMedGoogle Scholar
  16. Rowe PS, de Zoysa PA, Dong R, Wang HR, White KE, Econs MJ, Oudet CL (2000) Mepe, a new gene expressed in bone marrow and tumors causing osteomalacia. Genomics 67:54–68CrossRefPubMedGoogle Scholar
  17. Sandhu HS, Khan SN (2003) Recombinant human bone morphogenetic protein-2: use in spinal fusion applications. J Bone Joint Surg Am 85-A Suppl 3:89–95Google Scholar
  18. Tam CS, Heersche JN, Jones G, Murray TM, Rasmussen H (1986) The effect of vitamin D on bone in vivo. Endocrinology 118:2217–2224PubMedGoogle Scholar
  19. Thompson Z, Miclau T, Hu D, Helms JA (2002) A model for intramembranous ossification during fracture healing. J Orthop Res 20:1091–1098CrossRefPubMedGoogle Scholar
  20. Valentin-Opran A, Wozney J, Csimma C, Lilly L, Riedel GE (2002) Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop 110–120Google Scholar
  21. Wallach S, Rousseau G, Martin L, Azria M (1999) Effects of calcitonin on animal and in vitro models of skeletal metabolism. Bone 25:509–516CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Chuanyong Lu
    • 1
  • Steve Huang
    • 1
  • Theodore Miclau
    • 1
  • Jill A. Helms
    • 1
  • Céline Colnot
    • 1
  1. 1.Department of Orthopaedic SurgeryUniversity of California at San FranciscoSan FranciscoUSA

Personalised recommendations